These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 21460032)

  • 21. Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease.
    Fierbinteanu Braticevici C; Sporea I; Panaitescu E; Tribus L
    Ultrasound Med Biol; 2013 Nov; 39(11):1942-50. PubMed ID: 23932277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T.
    Tang A; Dzyubak B; Yin M; Schlein A; Henderson WC; Hooker JC; Delgado TI; Middleton MS; Zheng L; Wolfson T; Gamst A; Loomba R; Ehman RL; Sirlin CB
    Eur Radiol; 2022 May; 32(5):2937-2948. PubMed ID: 34928415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography.
    Asbach P; Klatt D; Schlosser B; Biermer M; Muche M; Rieger A; Loddenkemper C; Somasundaram R; Berg T; Hamm B; Braun J; Sack I
    Radiology; 2010 Oct; 257(1):80-6. PubMed ID: 20679447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study.
    Han MAT; Vipani A; Noureddin N; Ramirez K; Gornbein J; Saouaf R; Baniesh N; Cummings-John O; Okubote T; Setiawan VW; Rotman Y; Loomba R; Alkhouri N; Noureddin M
    Liver Int; 2020 Sep; 40(9):2242-2251. PubMed ID: 32652744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Furlan A; Tublin ME; Yu L; Chopra KB; Lippello A; Behari J
    AJR Am J Roentgenol; 2020 Jan; 214(1):W20-W26. PubMed ID: 31714842
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.
    Pavlides M; Banerjee R; Tunnicliffe EM; Kelly C; Collier J; Wang LM; Fleming KA; Cobbold JF; Robson MD; Neubauer S; Barnes E
    Liver Int; 2017 Jul; 37(7):1065-1073. PubMed ID: 27778429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of nonalcoholic fatty liver disease (NAFLD) activity score (NAS) with multiparametric hepatic magnetic resonance imaging and elastography.
    Yin Z; Murphy MC; Li J; Glaser KJ; Mauer AS; Mounajjed T; Therneau TM; Liu H; Malhi H; Manduca A; Ehman RL; Yin M
    Eur Radiol; 2019 Nov; 29(11):5823-5831. PubMed ID: 30887196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of MR-based texture analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD).
    Cannella R; Borhani AA; Tublin M; Behari J; Furlan A
    Abdom Radiol (NY); 2019 May; 44(5):1816-1824. PubMed ID: 30788556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy.
    Idilman IS; Aniktar H; Idilman R; Kabacam G; Savas B; Elhan A; Celik A; Bahar K; Karcaaltincaba M
    Radiology; 2013 Jun; 267(3):767-75. PubMed ID: 23382293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visco-Elastic Parameters at Three-Dimensional MR Elastography for Diagnosing Non-Alcoholic Steatohepatitis and Substantial Fibrosis in Mice.
    Khalfallah M; Doblas S; Hammoutene A; Julea F; Postic C; Valla D; Paradis V; Garteiser P; Van Beers BE
    J Magn Reson Imaging; 2024 Jan; 59(1):97-107. PubMed ID: 37158252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease.
    Lee YS; Yoo YJ; Jung YK; Kim JH; Seo YS; Yim HJ; Kim IH; Lee SY; Kim BH; Kim JW; Lee CH; Yeon JE; Kwon SY; Um SH; Byun KS
    Clin Transl Gastroenterol; 2020 Apr; 11(4):e00157. PubMed ID: 32251018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
    Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
    Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MR elastography of the liver at 3.0 T in diagnosing liver fibrosis grades; preliminary clinical experience.
    Yoshimitsu K; Mitsufuji T; Shinagawa Y; Fujimitsu R; Morita A; Urakawa H; Hayashi H; Takano K
    Eur Radiol; 2016 Mar; 26(3):656-63. PubMed ID: 26060066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic MR Elastography: Clinical Performance in a Series of 1377 Consecutive Examinations.
    Yin M; Glaser KJ; Talwalkar JA; Chen J; Manduca A; Ehman RL
    Radiology; 2016 Jan; 278(1):114-24. PubMed ID: 26162026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of Visceral Fat Volume and Its Correlation with the Severity of Hepatic Fibrosis in Patients with NAFLD.
    Varghese J; Devadas K; Joseph RC; Oommen TT; Hareendran A; Nahaz N; Narayanan V; George B
    J Assoc Physicians India; 2022 Sep; 70(9):11-12. PubMed ID: 36082882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative Liver MRI-Biopsy Correlation in Pediatric and Young Adult Patients With Nonalcoholic Fatty Liver Disease: Can One Be Used to Predict the Other?
    Dillman JR; Trout AT; Costello EN; Serai SD; Bramlage KS; Kohli R; Xanthakos SA
    AJR Am J Roentgenol; 2018 Jan; 210(1):166-174. PubMed ID: 29045180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Performance of MR Elastography for Liver Fibrosis in Children and Young Adults with a Spectrum of Liver Diseases.
    Trout AT; Sheridan RM; Serai SD; Xanthakos SA; Su W; Zhang B; Wallihan DB
    Radiology; 2018 Jun; 287(3):824-832. PubMed ID: 29470938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver fibrosis: noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease.
    Takeuchi H; Sugimoto K; Oshiro H; Iwatsuka K; Kono S; Yoshimasu Y; Kasai Y; Furuichi Y; Sakamaki K; Itoi T
    J Med Ultrason (2001); 2018 Apr; 45(2):243-249. PubMed ID: 29128938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis.
    Lee JI; Lee HW; Lee KS
    World J Gastroenterol; 2019 Sep; 25(33):4959-4969. PubMed ID: 31543686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.